The Scripps Cardiomyopathy and Cardio-Oncology Symposium is designed to provide a state-of-the-art, comprehensive, case-based curriculum that addresses important clinical topics relevant to cardiomyopathy and cardiovascular health of cancer survivors. Cardio-oncology is a growing field that has great importance as newly developed cancer treatments improve cancer survival rates but can be associated with cardiovascular toxicities. Similarly cardiac amyloidosis is a burgeoning disease with exciting new treatments. The program is intended for those involved in the care of patients with cardiomyopathies, diastolic heart failure, chemotherapy or radiation induced heart disease, pulmonary hypertension, and cardiomyopathy related arrhythmic diseases.
Nationally recognized faculty will cover challenging heart failure topics related to common cardiomyopathies, role of hemodynamic testing, latest structural heart therapies, ventricular assist devices and transplantation, cardio-oncology, cardiac imaging, electrophysiology, and genomics. The goal of the conference is for participants to return to their practice equipped with the latest evidence base and practical information to improve patient care.